Radiation-Induced Lung Injury With Lung Cancer Treated With the Combination Therapy of Nintedanib and Dexamethasone

por Itano, Junko, Kimura, Goro, Ninomiya, Kiichiro, Tanimoto, Yasushi
Publicado 2023

A suspected case of rocuronium–sugammadex complex-induced anaphylactic shock after cesarean section

por Yamaoka, Masakazu, Deguchi, Miki, Ninomiya, Kiichiro, Kurasako, Toshiaki, Matsumoto, Mutsuko
Publicado 2016

Congestive Heart Failure During Osimertinib Treatment for Epidermal Growth Factor Receptor (EGFR)-mutant Non-small Cell Lung Cancer (NSCLC)

por Watanabe, Hiromi, Ichihara, Eiki, Kano, Hirohisa, Ninomiya, Kiichiro, Tanimoto, Mitsune, Kiura, Katsuyuki
Publicado 2017

Clinical significance of repeat rebiopsy in detecting the EGFR T790M secondary mutation in patients with non-small cell lung cancer

por Ichihara, Eiki, Hotta, Katsuyuki, Kubo, Toshio, Higashionna, Tsukasa, Ninomiya, Kiichiro, Ohashi, Kadoaki, Tabata, Masahiro, Maeda, Yoshinobu, Kiura, Katsuyuki
Publicado 2018

Fulminant Myocarditis for Non-small-cell Carcinoma of the Lung with Nivolumab and Ipilimumab Plus Chemotherapy

por Nishimura, Tomoka, Ninomiya, Kiichiro, Nakashima, Mitsutaka, Akagi, Satoshi, Kuribayashi, Tadahiro, Higo, Hisao, Hotta, Katsuyuki, Maeda, Yoshinobu, Ito, Hiroshi, Kiura, Katsuyuki
Publicado 2022

Pneumocystis Pneumonia Concomitant with Ectopic ACTH Syndrome Caused by a Large Cell Neuroendocrine Carcinoma of the Thymus

por Oda, Naohiro, Miyahara, Nobuaki, Tabata, Masahiro, Minami, Daisuke, Ninomiya, Kiichiro, Kanehiro, Arihiko, Komatsubara, Motoshi, Inagaki, Kenichi, Tanimoto, Mitsune, Kiura, Katsuyuki
Publicado 2017

Short‐term safety of an anti‐severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine for patients with advanced lung cancer treated with anticancer drugs: A multicent...

por Tamura, Tomoki, Ninomiya, Kiichiro, Kubo, Toshio, Kuyama, Shoichi, Tachibana, Sayaka, Inoue, Koji, Chikamori, Kenichi, Kudo, Kenichiro, Ochi, Nobuaki, Harada, Daijiro, Maeda, Yoshinobu, Kiura, Katsuyuki
Publicado 2021

Safety of anti‐SARS‐CoV‐2 messenger RNA vaccine in lung cancer patients undergoing anticancer chemotherapy: A multicenter, prospective, observational, patient‐reported outcome stud...

por Harada, Daijiro, Tamura, Tomoki, Ninomiya, Kiichiro, Kubo, Toshio, Kuyama, Shoichi, Tachibana, Sayaka, Inoue, Koji, Chikamori, Kenichi, Kudo, Kenichiro, Ochi, Nobuaki, Maeda, Yoshinobu, Kiura, Katsuyuki
Publicado 2022

MET or NRAS amplification is an acquired resistance mechanism to the third-generation EGFR inhibitor naquotinib

por Ninomiya, Kiichiro, Ohashi, Kadoaki, Makimoto, Go, Tomida, Shuta, Higo, Hisao, Kayatani, Hiroe, Ninomiya, Takashi, Kubo, Toshio, Ichihara, Eiki, Hotta, Katsuyuki, Tabata, Masahiro, Maeda, Yoshinobu, Kiura, Katsuyuki
Publicado 2018

Successful and Prompt Treatment with Tepotinib for Lung Adenocarcinoma Harboring MET Exon 14 Skipping Mutation Combined with Lung Abscess Formation: A Case Report

por Makimoto, Go, Shimonishi, Atsushi, Ohashi, Kadoaki, Ninomiya, Kiichiro, Higo, Hisao, Kato, Yuka, Fujii, Masanori, Kubo, Toshio, Ichihara, Eiki, Hotta, Katsuyuki, Tabata, Masahiro, Maeda, Yoshinobu, Kiura, Katsuyuki
Publicado 2022

Massive hemoptysis in a post-operative patient with recurrent lung cancer successfully treated by the combination therapy of Endobronchial Watanabe Spigot and bronchial artery embo...

por Taoka, Masataka, Makimoto, Go, Umakoshi, Noriyuki, Ninomiya, Kiichiro, Higo, Hisao, Kato, Yuka, Fujii, Masanori, Kubo, Toshio, Ichihara, Eiki, Ohashi, Kadoaki, Hotta, Katsuyuki, Tabata, Masahiro, Maeda, Yoshinobu, Kiura, Katsuyuki
Publicado 2022

Utility of immune checkpoint inhibitors in non‐small‐cell lung cancer patients with poor performance status

por Kano, Hirohisa, Ichihara, Eiki, Harada, Daijiro, Inoue, Koji, Kayatani, Hiroe, Hosokawa, Shinobu, Kishino, Daizo, Watanabe, Kazuhiko, Ochi, Nobuaki, Oda, Naohiro, Hara, Naofumi, Ninomiya, Kiichiro, Hotta, Katsuyuki, Maeda, Yoshinobu, Kiura, Katsuyuki
Publicado 2020

Triple therapy with osimertinib, bevacizumab and cetuximab in EGFR-mutant lung cancer with HIF-1α/TGF-α expression

por Nishii, Kazuya, Ohashi, Kadoaki, Watanabe, Hiromi, Makimoto, Go, Nakasuka, Takamasa, Higo, Hisao, Ninomiya, Kiichiro, Kato, Yuka, Kubo, Toshio, Rai, Kammei, Ichihara, Eiki, Hotta, Katsuyuki, Tabata, Masahiro, Maeda, Yoshinobu, Kiura, Katsuyuki
Publicado 2021

Marginal Zone Lymphoma and Lung Adenocarcinoma with an EGFR Exon 19 E746-S752del Mutation in a Patient with IgG4-related Disease

por Okawa, Sachi, Rai, Kammei, Fujii, Nobuharu, Gion, Yuka, Ninomiya, Kiichiro, Kato, Yuka, Taniguchi, Akihiko, Kubo, Toshio, Ichihara, Eiki, Ohashi, Kadoaki, Miyahara, Nobuaki, Hotta, Katsuyuki, Tabata, Masahiro, Maeda, Yoshinobu, Kiura, Katsuyuki
Publicado 2021

Pulmonary Aspergilloma and Allergic Bronchopulmonary Aspergillosis Following the 2018 Heavy Rain Event in Western Japan

por Ando, Eri, Nakasuka, Takamasa, Kubo, Toshio, Taniguchi, Akihiko, Ninomiya, Kiichiro, Kato, Yuka, Ichihara, Eiki, Ohashi, Kadoaki, Rai, Kammei, Hotta, Katsuyuki, Yamane, Masaomi, Miyahara, Nobuaki, Tabata, Masahiro, Maeda, Yoshinobu, Kiura, Katsuyuki
Publicado 2021

Combined effect of cabozantinib and gefitinib in crizotinib‐resistant lung tumors harboring ROS1 fusions

por Kato, Yuka, Ninomiya, Kiichiro, Ohashi, Kadoaki, Tomida, Shuta, Makimoto, Go, Watanabe, Hiromi, Kudo, Kenichiro, Matsumoto, Shingo, Umemura, Shigeki, Goto, Koichi, Ichihara, Eiki, Ninomiya, Takashi, Kubo, Toshio, Sato, Akiko, Hotta, Katsuyuki, Tabata, Masahiro, Toyooka, Shinichi, Maeda, Yoshinobu, Kiura, Katsuyuki
Publicado 2018

Identification of targetable kinases in idiopathic pulmonary fibrosis

por Higo, Hisao, Ohashi, Kadoaki, Tomida, Shuta, Okawa, Sachi, Yamamoto, Hiromasa, Sugimoto, Seiichiro, Senoo, Satoru, Makimoto, Go, Ninomiya, Kiichiro, Nakasuka, Takamasa, Nishii, Kazuya, Taniguchi, Akihiko, Kubo, Toshio, Ichihara, Eiki, Hotta, Katsuyuki, Miyahara, Nobuaki, Maeda, Yoshinobu, Toyooka, Shinichi, Kiura, Katsuyuki
Publicado 2022

CDK4/6 signaling attenuates the effect of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer

por Hara, Naofumi, Ichihara, Eiki, Kano, Hirohisa, Ando, Chihiro, Morita, Ayako, Nishi, Tatsuya, Okawa, Sachi, Nakasuka, Takamasa, Hirabae, Atsuko, Abe, Masaya, Asada, Noboru, Ninomiya, Kiichiro, Makimoto, Go, Fujii, Masanori, Kubo, Toshio, Ohashi, Kadoaki, Hotta, Katsuyuki, Tabata, Masahiro, Maeda, Yoshinobu, Kiura, Katsuyuki
Publicado 2023

Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK‐rearranged non‐small cell lung cancer

por Ando, Chihiro, Ichihara, Eiki, Nishi, Tatsuya, Morita, Ayako, Hara, Naofumi, Takada, Kenji, Nakasuka, Takamasa, Watanabe, Hiromi, Kano, Hirohisa, Nishii, Kazuya, Makimoto, Go, Kondo, Takumi, Ninomiya, Kiichiro, Fujii, Masanori, Kubo, Toshio, Ohashi, Kadoaki, Matsuoka, Ken‐ichi, Hotta, Katsuyuki, Tabata, Masahiro, Maeda, Yoshinobu, Kiura, Katsuyuki
Publicado 2023

VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers

por Watanabe, Hiromi, Ichihara, Eiki, Kayatani, Hiroe, Makimoto, Go, Ninomiya, Kiichiro, Nishii, Kazuya, Higo, Hisao, Ando, Chihiro, Okawa, Sachi, Nakasuka, Takamasa, Kano, Hirohisa, Hara, Naofumi, Hirabae, Atsuko, Kato, Yuka, Ninomiya, Takashi, Kubo, Toshio, Rai, Kammei, Ohashi, Kadoaki, Hotta, Katsuyuki, Tabata, Masahiro, Maeda, Yoshinobu, Kiura, Katsuyuki
Publicado 2021